DMPA-SC Access Collaborative: Putting a new type of injectable contraception within reach

June 18, 2018 by PATH

A community health worker's travel case of family planning options including the injectable contraceptive DMPA-SC (brand name Sayana Press)

Photo: PATH/Gabe Bienczycki

A new initiative led by PATH in partnership with John Snow, Inc., the DMPA-SC Access Collaborative works with ministries of health and partners to strengthen scale-up and build a robust global market for DMPA-SC as an important addition to the full range of contraceptive options.

Launched in 2017, the DMPA-SC Access Collaborative is a three-year initiative working in 8 to 12 countries to accelerate scale-up of DMPA-SC* (brand name Sayana® Press) while strengthening health systems and markets for family planning. Initial focus countries include Democratic Republic of the Congo, Kenya, Madagascar, Nigeria, Senegal, Uganda, and Zambia.

The Access Collaborative provides health ministries and country partners with a range of support, including dedicated technical assistance to integrate DMPA-SC alongside other methods in national family planning programs. The Access Collaborative also shares information gathered across countries with international donors to help shape the global market for DMPA-SC, with the ultimate aim of dependable supply available at affordable prices.

In addition, the Access Collaborative facilitates learning across countries by exchanging information, results, and lessons learned; troubleshooting challenges; and accelerating the adoption of best practices through two interactive, virtual Learning and Action Networks—one Anglophone and one Francophone.

We encourage new country partners to join our efforts. For more information, visit, sign up for our newsletter, or email

“ The introduction of DMPA-SC brings a new tool to the existing range of contraceptive methods in Senegal, enriching family planning service offerings here. ”
— Maymouna Ba, PATH DMPA-SC Research Officer, Senegal


*DMPA-SC: Subcutaneous depot medroxyprogesterone acetate.
Sayana Press is a registered trademark of Pfizer Inc.

Read More